دورية أكاديمية
Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice.
| العنوان: | Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice. |
|---|---|
| المؤلفون: | Chat VS; Dr. Chat is from the Medical College of Georgia, Augusta University. Dr. Kearns is from Loma Linda University School of Medicine, California. Dr. Uppal is from Albany Medical College, New York. Dr. Han is from the Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Kearns DG; Dr. Chat is from the Medical College of Georgia, Augusta University. Dr. Kearns is from Loma Linda University School of Medicine, California. Dr. Uppal is from Albany Medical College, New York. Dr. Han is from the Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Uppal SK; Dr. Chat is from the Medical College of Georgia, Augusta University. Dr. Kearns is from Loma Linda University School of Medicine, California. Dr. Uppal is from Albany Medical College, New York. Dr. Han is from the Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Han G; Dr. Chat is from the Medical College of Georgia, Augusta University. Dr. Kearns is from Loma Linda University School of Medicine, California. Dr. Uppal is from Albany Medical College, New York. Dr. Han is from the Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida., Wu JJ; Dr. Chat is from the Medical College of Georgia, Augusta University. Dr. Kearns is from Loma Linda University School of Medicine, California. Dr. Uppal is from Albany Medical College, New York. Dr. Han is from the Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell. Dr. Wu is from the Department of Dermatology, University of Miami Miller School of Medicine, Florida. |
| المصدر: | Cutis [Cutis] 2022 Aug; Vol. 110 (2 Suppl), pp. 8-14. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 0006440 Publication Model: Print Cited Medium: Internet ISSN: 2326-6929 (Electronic) Linking ISSN: 00114162 NLM ISO Abbreviation: Cutis Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Parsippany, NJ : Frontline Medical Communications Original Publication: New York : Cahners Pub Co. |
| مواضيع طبية MeSH: | Coal Tar*/adverse effects , Dermatologic Agents* , Psoriasis*/chemically induced , Psoriasis*/drug therapy, Administration, Topical ; Anthralin/therapeutic use ; Calcineurin Inhibitors/therapeutic use ; Emollients/therapeutic use ; Humans ; Retinoids/therapeutic use ; Salicylic Acid ; Steroids/therapeutic use ; Vitamin D |
| مستخلص: | Topical medications have high utility in the treatment of psoriasis because of their localized effect and ability to be used as both monotherapy and adjunctive therapy. The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) published guidelines in 2020 regarding the management of psoriasis with topical therapies. These guidelines are a framework that assist clinicians treating psoriasis patients with topical agents including steroids, calcineurin inhibitors (CNIs), vitamin D analogues, retinoids (tazarotene), emollients, keratolytics (salicylic acid), anthracenes (anthralin), and keratoplastics (coal tar). This review presents these evidence-based recommendations in a form that dermatologists can readily apply to their clinical practice. The selection of an appropriate topical therapy, effective combination therapies, duration of use, and adverse events are addressed. |
| المشرفين على المادة: | 0 (Calcineurin Inhibitors) 0 (Dermatologic Agents) 0 (Emollients) 0 (Retinoids) 0 (Steroids) 1406-16-2 (Vitamin D) 8007-45-2 (Coal Tar) O414PZ4LPZ (Salicylic Acid) U8CJK0JH5M (Anthralin) |
| تواريخ الأحداث: | Date Created: 20221011 Date Completed: 20221013 Latest Revision: 20221013 |
| رمز التحديث: | 20231215 |
| DOI: | 10.12788/cutis.0573 |
| PMID: | 36219602 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2326-6929 |
|---|---|
| DOI: | 10.12788/cutis.0573 |